Controversial issues in the neoadjuvant treatment of triple-negative breast cancer

Triple-negative breast cancer (TNBC), as a collective group of heterogenous tumours, displays the highest rate of distant recurrence and lowest survival from metastatic disease across breast cancer subtypes. However, a subset of TNBC display impressive primary tumour response to neoadjuvant chemothe...

Descripción completa

Detalles Bibliográficos
Autores principales: Fitzpatrick, Amanda, Tutt, Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
TNBC in 2019: Promising Signals for the Treatment of a Formidable Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6826917/
https://www.ncbi.nlm.nih.gov/pubmed/31700549
http://dx.doi.org/10.1177/1758835919882581

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6826917/
https://www.ncbi.nlm.nih.gov/pubmed/31700549
http://dx.doi.org/10.1177/1758835919882581

Ejemplares similares